cinnamamide has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furukawa, H; Ito, C; Itoigawa, M; Matsui, T; Okada, T | 1 |
| Jiang, X; Zhen, Y | 1 |
2 other study(ies) available for cinnamamide and Disease Models, Animal
| Article | Year |
|---|---|
Lansiumamide B and SB-204900 isolated from Clausena lansium inhibit histamine and TNF-α release from RBL-2H3 cells.
Topics: Animals; Calcimycin; Calcium Ionophores; Cell Line; Cell Survival; Cinnamates; Clausena; Cyclooxygenase 2; Disease Models, Animal; Histamine; Interleukin-6; Leukemia, Basophilic, Acute; Mast Cells; p38 Mitogen-Activated Protein Kinases; Plant Extracts; Plant Leaves; Rats; Tumor Necrosis Factor-alpha | 2013 |
Cinnamamide, an antitumor agent with low cytotoxicity acting on matrix metalloproteinase.
Topics: Animals; Antineoplastic Agents; Cell Division; Cinnamates; Disease Models, Animal; Humans; KB Cells; Matrix Metalloproteinase 2; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured | 2000 |